does blue cross blue shield pay for semaglutide could rise with obesity drug costs surge Blue Cross Blue Shield plans

The starting price for your first consultation and monthly pen is 125

Semaglutide, a GLP-1 medication primarily prescribed for people with Type 2 diabetes, is also FDA-approved for weight loss in people with obesity

For many patients, early changes may appear within weeks 2 to 4, especially when appetite suppression leads to reduced calorie intake

Judicial Panel on Multidistrict Litigation

Its mechanisms of action include: Stimulating insulin secretion from pancreatic -cells in a glucose-dependent manner Suppressing glucagon release , reducing hepatic glucose production Slowing gastric emptying , which reduces postprandial glucose spikes Promoting satiety , leading to reduced caloric intake and potential weight loss Semaglutide has a half-life of approximately 1 week , allowing for once-weekly dosing , which improves adherence compared to daily injections